GE Healthcare

GE Healthcare Set to become a Standalone Company

Under a tax-free scheme, General Electric (GE) is officially carving out its healthcare business into a standalone company. The move that had been expected to take place several times over the past three years but repeatedly stalled is now set to be completed in early 2023. The US conglomerate plans to retain a stake of just under 20%.

GE Healthcare invests at the MaRS facility in Toronto

Marie Ffolkes Designated as Air Products President Industrial Gases–Americas

Rentschler Expands European Manufacturing Capabilities with GE Bioprocess Technologies

GE Healthcare Life Sciences and Rentschler Mark Handover

Sharon Johnson to Head Catalent’s Quality, Product Development & Regulatory Affairs

GE Healthcare Life Sciences With New Istanbul Center

After Tech Success, Israel Seeks Life Sciences Growth

An Economy Built on Ideas

GE Healthcare To Invest $1 Billion In New Oncology Solutions